Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 1 | Cost Effectiveness and Resource Allocation

Fig. 1

From: Validation of the UKPDS 82 risk equations within the Cardiff Diabetes Model

Fig. 1

Observed versus predicted endpoints stratified by validations study, endpoint and UKPDS equations. Overall validation coefficient of determination for UKPDS 68, R2 = 0.851; UKPDS 82, R2 = 0.870. ACM all-cause mortality, CHF congestive heart failure, CHD coronary heart disease, CV cardiovascular, MI myocardial infarction, ESRD end stage renal disease, MVD microvascular disease, PE primary endpoint.

Back to article page